improving interprofessional management and clinical outcomes with parp inhibitors for advanced ov...
Published 5 months ago • 28 plays • Length 1:00:00Download video MP4
Download video MP3
Similar videos
-
55:30
improving interprofessional management and clinical outcomes with parp inhibitors for advanced ov...
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
31:13
parp inhibitors and immunotherapy - dr yvette drew
-
40:20
parp inhibitors treatment update - summit 2021
-
35:35
maximizing the potential of parp inhibitors as first-line maintenance therapy in ovarian cancer
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
40:21
parp inhibitors in advanced prostate cancer care
-
42:41
round-table discussion on parp inhibitor
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
10:36
parp inhibitor trial updates
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
3:26
new treatment on the horizon | parp inhibitor - olaparib
-
6:25
combinations with parp inhibitors for ovarian cancer
-
4:59
future role of parp inhibition in brca breast cancer
-
15:43
clinical data with parp inhibitors in ovarian cancer
-
17:35
expert perspectives: the clinical potential of parp inhibitors in ovarian cancer
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer